A New Approach to Cancer

Exploiting Cancer's Vulnerabilities

Multiple Clinical Candidates with Pan-Cancer Potential

Treadwell Therapeutics is a clinical-stage oncology company exploiting cancer cells’ vulnerabilities to develop first-in-class and best-in-class small molecules to address unmet needs in patients with highly aggressive cancers.